Log In
Print this Print this

astuprotimut-R (MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI)) (GSK1572932A)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCancer vaccine consisting of recombinant MAGEA3 protein and the AS15 immunostimulant
Molecular Target Melanoma-associated antigen A3 (MAGEA3)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today